Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
08/25/2015 08/26/2015 08/27/2015 08/28/2015 08/31/2015 Date
262.3(c) 257(c) 267(c) 263.2(c) 264 Last
2 741 986 2 746 472 1 638 825 1 690 716 1 040 120 Volume
+3.27% -2.02% +3.89% -1.42% +0.30% Change
More quotes
Financials ( CHF)
Sales 2015 48 146 M
EBIT 2015 16 949 M
Net income 2015 10 700 M
Debt 2015 10 753 M
Yield 2015 3,15%
Sales 2016 50 374 M
EBIT 2016 18 202 M
Net income 2016 12 070 M
Debt 2016 6 571 M
Yield 2016 3,36%
PER 2015 20,63
PER 2016 18,37
EV / Sales 2015 4,94x
EV / Sales 2016 4,64x
Capitalization 227 115 M
More Financials
Company
Roche Holding AG operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics.It operates business through two divisons: Pharmaceuticals and Diagnostics.The Pharmaceuticals divison comprises the two business segments Roche Pharmaceuticals and Chugai,... 
Sector
Pharmaceuticals
Calendar
09/09Presentation
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
08/24 AstraZeneca names Genentech's Bohen as chief medical officer
08/19DJRoche Buys U.S. Gene-Technology Company Kapa Biosystems
08/17 ROCHE : Pivotal Phase II Study Showed Genentech’s Investigational Immunoth..
08/13 Roche buys 'superbug' diagnostics firm for up to $425 million
08/13DJRoche Buys U.S. Company GeneWEAVE BioSciences Inc.
08/12 ROCHE : Pivotal Phase II Study of Investigational Medicine Venetoclax Met Primar..
08/05 Shire seen having to sweeten $30 billion offer to win Baxalta
08/03 Analysis - New cocktails to test limits of cancer drug pricing
More news
Sector news : Pharmaceuticals - NEC
02:57a Interim report for Saniona AB (publ) January - June 2015
08/30 BRISTOL MYERS SQUIBB : -Myers, QIMR Collaborate To Discover Novel Immuno-Oncolog..
08/30 BRISTOL MYERS SQUIBB : and QIMR Berghofer Medical Research Institute Announce Wo..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/27 PREMARKET BIOTECH DIGEST : CLL Treatment, Gilead CEO Sells, Acelity IPO
08/25 PREMARKET BIOTECH DIGEST : SA Author On Valeant, Stocks Tumble, Novartis Promact..
08/24 BUYING AMID THE SELLOFF, PHARMA M&A, : SA Biotech Panel Discussion
08/24 Roche buys nucleic acid purification technology from Lumora
08/24 Gilead's Pipeline, Part 3, With Summary Comments


Comments 
Advertisement
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Technical analysis trends ROCHE HOLDING LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions